Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-06-009961
Filing Date
2006-03-15
Accepted
2006-03-15 12:52:57
Documents
12
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 v037548_10k.htm 10-K 2261894
2 v037548_ex10-29.htm EX-10.29 61370
3 v037548_ex10-42.htm EX-10.42 76989
4 v037548_ex10-43.htm EX-10.43 125914
5 v037548_ex10-44.htm EX-10.44 83074
6 v037548_ex10-45.htm EX-10.45 75598
7 v037548_ex10-46.htm EX-10.46 536437
8 v037548_ex21-1.htm EX-21.1 2316
9 v037548_ex23-1.htm EX-23.1 3586
10 v037548_ex31-1.htm EX-31.1 13707
11 v037548_ex31-2.htm EX-31.2 13413
12 v037548_ex32.htm EX-32 10163
  Complete submission text file 0001144204-06-009961.txt   3265851
Mailing Address 433 HACKENSACK AVENUE HACKENSACK NJ 07601
Business Address 433 HACKENSACK AVENUE HACKENSACK NJ 07601 2019680980
DOV PHARMACEUTICAL INC (Filer) CIK: 0001066833 (see all company filings)

EIN.: 223374365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-49730 | Film No.: 06687430
SIC: 2834 Pharmaceutical Preparations